July 25, 2017 5:30 AM ET

Biotechnology

Company Overview of Axovant Sciences Ltd.

Executive Profile

Gregory M. Weinhoff M.D., MBA

Principal Financial Officer, Axovant Sciences Ltd.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 9 different industries.

See Board Relationships
46$2,369,604
As of Fiscal Year 2017

Background

Dr. Gregory M. Weinhoff, also known as Greg, M.D., MBA has been Principal Financial Officer of Axovant Sciences Ltd. since August 12, 2015. Dr. Weinhoff serves as a Partner at CHL Medical Partners. He joined the CHL in 2001 and is active in the biotechnology, molecular diagnostics, medical device and healthcare services sectors. Dr. Weinhoff was employed by Collinson Howe Venture Partners from 2001 to August 2015. From 2000 to 2001, he served as a Senior Associate at ...

Corporate Headquarters

20-22 Bedford Row
London, -- WC1R 4JS

United Kingdom

Phone: 44 20 3318 9708
Fax: --

Board Members Memberships

Director
Director
Executive Chairman
Director

Education

MBA
Harvard Business School
BA
Harvard College
MD
Harvard Medical School

Other Affiliations

Annual Compensation

Salary$360,500
Total Annual Compensation$360,500

Stocks Options

Exercisable Options$170,286
Unexercisable Options$483,810
Total Number of Options$654,096

Total Compensation

Total Annual Cash Compensation$561,028
Total Short Term Compensation$360,500
Total Calculated Compensation$2,369,604
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Axovant Sciences Ltd., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.